[1] |
FENG Zhiyin, WU Yixian, HA Xiaodan, CHEN Wujin, LI Xiumei, DONG Juanjuan.
Detection of p38MAPK gene in plasma cell-free DNA among patients with high incidence of esophageal cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(2): 105-109.
|
[2] |
LU Xuemei, XU Mingyan, LIU Tingying, ZHANG Qiufang, DENG Xiaoling.
Associations between MTHFR rs1801131 polymorphisms and non-syndromic cleft lips with or without cleft palates in a Han population, Chaoshan, China
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 334-337,344.
|
[3] |
ZHENG Jiantao, YANG Yong, ZHOU Dong.
Clinical significance of CX43 expression and immune cell infiltration in glioma: based on TCGA data analyses
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 250-254,261.
|
[4] |
XU Qilu, GAO Hui, RAN Xuehong, WANG Junjun, ZHANG Junying, LIU Liping.
Gene mutation and clinical correlation analyses of myeloid leukemia with abnormal karyotypes
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 296-301,306.
|
[5] |
JIAO Wenjing, GUO Xiujuan, MA Ming, SHAO Junguo, ZHANG Jinyan.
Comparative efficacies between concurrent chemo-radiotherapy and radiotherapy alone in elderly patients with locally advanced esophageal cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 124-128.
|
[6] |
CHEN Wanxian, WANG Simeng, CHEN Zhangyu, WANG Panji, ZHENG Chunwen, LI Enmin, XU Liyan.
CASIN, a CDC42 inhibitor, inhibited viability and migration of esophageal carcinoma cells in vitro
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 136-142.
|
[7] |
SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo.
Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
|
[8] |
DU Qiang, YAO Yiyong, ZENG Gang.
Expression and clinical significance of ASPM in lung adenocarcinoma according to the TCGA database
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 457-463.
|
[9] |
FENG Min, ABBIE·Mohetar, SHI Jingyi, ZUKELAI·Alijiang, LI Yongxiang, YAN Changshun, LI Xiumei.
Expression of miR-143, miR-145 and Survivin mRNA in esophageal cancers among Kazaks
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 29-32.
|
[10] |
MA Lili, ZHANG Shuli, LI Qin, XU Peng, FENG Min, LI Xiumei.
Screening and identification of differentially expressed miRNAs in esophageal cancers among Xinjiang Kazaks
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 52-56.
|
[11] |
GAO Jie, ZHANG Xiao, WEI Chao.
Involvement of differentially expressed miRNA in prognosis of pancreatic cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 173-179.
|
[12] |
LIU Ying, WANG Ke, HE Yangting, XIAO Jinrong, WANG Huanzhuo, LI Yangkai, WEI Sheng.
Prognosis-associated lncRNA signature in lung squamous cell carcinomas based on TCGA database
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 468-472,478.
|
[13] |
XU Shizhang, XIE Minjuan.
Relation between ACE gene polymorphism and pediatric idiopathic steroid-sensitive nephrotic syndrome: a meta-analysis
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 447-451.
|
[14] |
YANG Xingxiao, ZOU Naiyi, LI Qiaofang, ZHANG Xueyuan, SONG Heng, LIU Zhikun, MA Ming, SHAN Baoen, ZHU Shuchai.
Significance in expression of RNF2 and PCNA proteins in esophageal squamous cancer cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(4): 254-257.
|
[15] |
HE Shuzhi, ZHAO Yue, LIU Yang, YANG Liucai, CHEN Ping, LIU Ran.
Evaluation of the quality of life among esophageal cancer patients who received chemotherapy
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(6): 437-444,449.
|